Teleflex Incorporated (TFX)

Market Cap	8.70B
Revenue (ttm)	3.03B
Net Income (ttm)	237.44M
Shares Out	46.44M
EPS (ttm)	5.03
PE Ratio	37.28
Forward PE	12.51
Dividend	$1.36 (0.73%)
Ex-Dividend Date	Nov 15, 2024

Volume	500,943
Open	192.26
Previous Close	193.07
Day's Range	185.84 - 192.26
52-Week Range	185.84 - 257.85
Beta	1.18
Analysts	Buy
Price Target	259.00 (+38.19%)
Earnings Date	Oct 31, 2024

About TFX

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional prod...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1943
• Employees: 14,500
• Stock Exchange: NYSE
• Ticker Symbol: TFX
• Website: https://www.teleflex.com

Financial Performance

In 2023, Teleflex's revenue was $2.97 billion, an increase of 6.57% compared to the previous year's $2.79 billion. Earnings were $356.33 million, a decrease of -1.88%.

Analyst Forecast

According to 9 analysts, the average rating for TFX stock is "Buy." The 12-month stock price forecast is $259.0, which is an increase of 38.19% from the latest price.

Price Target

$259.0

(38.19% upside)

Analyst Consensus: Buy